| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | 805.51% | HC Wainwright & Co. | → $23 | Reiterates | Buy → Buy |
| 07/10/2023 | 766.14% | Guggenheim | → $22 | Assumes | → Buy |
| 05/08/2023 | 805.51% | HC Wainwright & Co. | → $23 | Reiterates | → Buy |
| 05/01/2023 | 805.51% | HC Wainwright & Co. | → $23 | Reiterates | → Buy |
| 03/09/2023 | 805.51% | HC Wainwright & Co. | → $23 | Reiterates | → Buy |
| 08/10/2022 | 805.51% | HC Wainwright & Co. | $30 → $23 | Maintains | Buy |
| 05/09/2022 | 1081.1% | HC Wainwright & Co. | $40 → $30 | Maintains | Buy |
| 11/08/2021 | 1238.58% | Oppenheimer | $32 → $34 | Maintains | Outperform |
| 06/04/2021 | 1474.8% | HC Wainwright & Co. | → $40 | Initiates Coverage On | → Buy |
| 10/19/2020 | 1868.5% | Cowen & Co. | → $50 | Initiates Coverage On | → Outperform |
| 07/29/2020 | 1868.5% | Guggenheim | → $50 | Initiates Coverage On | → Buy |
| 01/22/2020 | 1671.65% | Ladenburg Thalmann | → $45 | Initiates Coverage On | → Buy |
What is the target price for Protara Therapeutics (TARA)?
The latest price target for Protara Therapeutics (NASDAQ: TARA) was reported by HC Wainwright & Co. on August 4, 2023. The analyst firm set a price target for $23.00 expecting TARA to rise to within 12 months (a possible 805.51% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Protara Therapeutics (TARA)?
The latest analyst rating for Protara Therapeutics (NASDAQ: TARA) was provided by HC Wainwright & Co., and Protara Therapeutics reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Protara Therapeutics (TARA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Protara Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Protara Therapeutics was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
Is the Analyst Rating Protara Therapeutics (TARA) correct?
While ratings are subjective and will change, the latest Protara Therapeutics (TARA) rating was a reiterated with a price target of $0.00 to $23.00. The current price Protara Therapeutics (TARA) is trading at is $2.54, which is within the analyst's predicted range.